Research output

  1. The anti-C5a antibody vilobelimab efficiently inhibits C5a in patients with severe COVID-19

    Research output: Contribution to journal › Article › Academic › peer-review

  2. Transfusion practice in the bleeding critically ill: An international online survey-The TRACE-2 survey

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Indoleamine 2,3-dioxygenase (IDO)-1 and IDO-2 activity and severe course of COVID-19

    Research output: Contribution to journal › Article › Academic › peer-review

View all (24) »

ID: 3341677